4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow NUF2 protein, human: new trials by email Literature Review of NUF2 protein, human trials Research Report on NUF2 protein, human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer HLA-A*2402restricted URLC10, CDCA1, and KIF20A peptides with adjuvant - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Shiga University | 6 | 2011-09-01 | 2019-03-19 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer HLA-A*2402-restricted CDCA1 and KIF20A peptides - Small Cell Lung Cancer | Phase 1 | Completed | Shiga University | 9 | 2010-02-01 | 2019-03-19 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer HLA-A*2402restricted URLC10, CDCA1, and KIF20A peptides - Non-Small Cell Lung Cancer | Phase 1 | Completed | Shiga University | 18 | 2010-02-01 | 2019-03-19 |
| Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer HLA-A*2402restricted URLC10, CDCA1, VEGFR1 and VEGFR2 - Non Small Cell Lung Cancer | Phase 1 | Completed | Fukushima Medical University | 6 | 2009-03-01 | 2013-08-15 |
Carcinoma, Non-Small-Cell Lung (3) · Lung Neoplasms (2) · Small Cell Lung Carcinoma (1)
Shiga University (3) · Fukushima Medical University (1)
Japan (4)